Elixir Capital Falls to 52-Week Low of Rs.91.85 Amidst Prolonged Downtrend

Stock Price Movement and Market Context

On 24 Nov 2025, Elixir Capital's share price reached Rs.91.85, representing the lowest point in the last 52 weeks. Despite this, the stock outperformed its sector by 0.37% on the day, showing a slight gain after two consecutive days of decline. However, the stock remains below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a sustained bearish trend.

In contrast, the broader market, represented by the Sensex, opened 88.12 points higher and was trading at 85,450.59, a 0.26% increase. The Sensex is currently 0.41% away from its 52-week high of 85,801.70 and has been on a three-week consecutive rise, gaining 2.68% during this period. Mega cap stocks have been leading the market's upward momentum, with the Sensex trading above its 50-day moving average, which itself is positioned above the 200-day moving average, signalling a bullish market environment overall.

Financial Performance and Valuation Metrics

Elixir Capital's financial indicators reveal a challenging operational landscape. Over the past year, the stock has generated a return of -51.51%, significantly underperforming the Sensex, which recorded an 8.01% return in the same period. The company’s net sales for the latest six months stood at Rs.22.01 crores, reflecting a contraction of 33.86% compared to previous periods. Similarly, the profit after tax (PAT) for the last six months was Rs.4.44 crores, showing a decline of 69.82%.

The company’s operating profits have shown a compound annual growth rate (CAGR) of -9.48%, indicating a reduction in profitability over the longer term. Additionally, profits have fallen by 102.5% over the past year, highlighting the severity of the earnings decline. Return on equity (ROE) is reported at -1, pointing to negative returns for shareholders during this period.

From a valuation perspective, Elixir Capital is trading at a price-to-book value of 0.9, which is considered expensive relative to its peers’ average historical valuations. This premium valuation exists despite the company’s negative earnings growth and subdued financial performance.

Comparison with Market and Sector Performance

While Elixir Capital has experienced a significant decline, the broader BSE500 index has recorded a positive return of 6.76% over the past year. This contrast emphasises the stock’s underperformance relative to the wider market. The NBFC sector, in which Elixir Capital operates, has generally seen mixed results, but the company’s stock has lagged behind sector averages.

The stock’s fall to Rs.91.85 is a stark contrast to its 52-week high of Rs.351.05, illustrating the extent of the downward price movement. This decline has occurred despite the Sensex’s positive trajectory and the overall market’s bullish signals, highlighting company-specific factors influencing the stock’s performance.

Shareholding and Corporate Structure

The majority shareholding in Elixir Capital is held by promoters, indicating concentrated ownership. This structure can influence corporate decisions and strategic direction, which may be relevant to the stock’s market behaviour and valuation.

Summary of Key Metrics

To summarise, Elixir Capital’s stock price has reached Rs.91.85, its lowest level in the past 52 weeks, reflecting a decline of approximately 73.8% from its peak of Rs.351.05. The company’s financial results over recent quarters have shown contraction in sales and profits, with negative returns on equity and a valuation that remains elevated relative to peers. The stock’s performance contrasts with the broader market’s positive trend, as the Sensex continues to approach its own 52-week high.

These factors collectively illustrate the challenges faced by Elixir Capital in maintaining its market valuation and financial health amid a competitive and dynamic NBFC sector.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →